Q&A with Dr. Elizabeth Brunk: Using AI and Single Cell Imaging to Halt Harmful DNA Changes in Cancer
Автор: PhRMAFoundation
Загружено: 2025-07-01
Просмотров: 34
Elizabeth Brunk, MSc, PhD, an assistant professor of pharmacology and chemistry at the University of North Carolina at Chapel Hill, is pioneering a novel approach to identify and target harmful extrachromosomal DNA (ecDNA) adaptations to guide better strategies for treating cancer.
Brunk received a PhRMA Foundation 2025 Faculty Starter Grant in Drug Discovery for her work integrating artificial intelligence with single cell imaging to analyze how cells adapt and alter their ecDNA in response to therapeutics. The goal is to target and prevent these harmful ecDNA changes, thus improving patient treatment responses and advancing durable treatments. Watch this video to learn more about Brunk and her research.
This video includes b-roll from the University of North Carolina at Chapel Hill Computational Medicine Program, courtesy of UNC-Chapel Hill and KathASK Films, LLC. View full video: • The Computational Medicine Program at UNC ... .
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
